Table 6 Percentages of patients meeting different levels of IBS-QOL total score improvement
Improvement from baseline to Week 12 | Placebo | Eluxadoline 100 mg | Difference between treatment groups |
|---|---|---|---|
0 | 80.3% | 90.6% | 10.30% |
5 | 70.4% | 80.5% | 10.11% |
10 | 57.9% | 74.2% | 16.32% |
15 | 46.1% | 62.9% | 16.84% |
20 | 32.2% | 52.8% | 20.59% |
25 | 21.7% | 41.5% | 19.80% |
30 | 19.1% | 30.8% | 11.74% |